| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 889-900, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
DD Nitsch, N Ghilardi, H Muhl, C Nitsch, B Brune and J Pfeilschifter
Department of Pharmacology, University of Basel, Switzerland.
Nitric oxide (NO) is a multipurpose messenger molecule, important for blood vessel relaxation, neuronal communication, and antimicrobial activities. The generation of NO from L-arginine is catalyzed by NO synthase (NOS). An inducible form of NOS, iNOS, was first characterized in macrophages and then in many other tissues and cells, including renal mesangial cells. Mesangial cells play a crucial role in the regulation of the glomerular filtration rate as well as in the pathophysiology of certain forms of glomerulonephritis in which mesangial cells and macrophages produce NO in high amounts. Because reports have associated NO production with apoptotic cell death in macrophages and we recently demonstrated NO-mediated apoptosis in mesangial cells, we searched for the relationship between in situ iNOS induction and apoptosis by iNOS immunocytochemistry and terminal desoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining. RAW 264.7 macrophages exhibited homogeneous iNOS expression and apoptotic nuclei in the iNOS-containing cells upon stimulation with interferon-gamma and lipopolysaccharide. In contrast, stimulated rat mesangial cells stained heterogeneously for iNOS, depending on cell passage and iNOS-stimulating pathway. Mesangial cells expressing iNOS did not display signs of apoptosis and, vice versa, cells showing characteristic features of apoptosis did not stain for iNOS. Thus, our study suggests that mesangial cells react to stimulation by interleukin- 1 and/or cAMP-elevating compounds with mutually exclusive responses, either by expression of iNOS or by undergoing programmed cell death.
This article has been cited by other articles:
![]() |
M. Deja, T. Busch, S. Bachmann, K. Riskowski, V. Campean, B. Wiedmann, M. Schwabe, B. Hell, J. Pfeilschifter, K. J. Falke, et al. Reduced Nitric Oxide in Sinus Epithelium of Patients with Radiologic Maxillary Sinusitis and Sepsis Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 281 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. MANDERSCHEID, U. K. MEßMER, R. FRANZEN, and J. PFEILSCHIFTER Regulation of Inhibitor of Apoptosis Expression by Nitric Oxide and Cytokines: Relation to Apoptosis Induction in Rat Mesangial Cells and RAW 264.7 Macrophages J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1151 - 1163. [Abstract] [Full Text] |
||||
![]() |
J. S. Duffield, L.-P. Erwig, X.-q. Wei, F. Y. Liew, A. J. Rees, and J. S. Savill Activated Macrophages Direct Apoptosis and Suppress Mitosis of Mesangial Cells J. Immunol., February 15, 2000; 164(4): 2110 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. FRANK, K. ZACHAROWSKI, G. M. WRAY, C. THIEMERMANN, and J. PFEILSCHIFTER Identification of copper/zinc superoxide dismutase as a novel nitric oxide-regulated gene in rat glomerular mesangial cells and kidneys of endotoxemic rats FASEB J, May 1, 1999; 13(8): 869 - 882. [Abstract] [Full Text] |
||||
![]() |
A. Huwiler, J. Pfeilschifter, and H. van den Bosch Nitric Oxide Donors Induce Stress Signaling via Ceramide Formation in Rat Renal Mesangial Cells J. Biol. Chem., March 12, 1999; 274(11): 7190 - 7195. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Closs, F. Enseleit, D. Koesling, J. M. Pfeilschifter, P. M. Schwarz, and U. Förstermann Coexpression of inducible NO synthase and soluble guanylyl cyclase in colonic enterocytes: a pathophysiologic signaling pathway for the initiation of diarrhea by gram-negative bacteria? FASEB J, December 1, 1998; 12(15): 1643 - 1649. [Abstract] [Full Text] |
||||
![]() |
S. N. Waddington, F. W. K. Tam, H. T. Cook, and V. Cattell Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells Am J Physiol Renal Physiol, March 1, 1998; 274(3): F473 - F480. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |